Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer-Reference-Cited by-同舟云学术

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Published:2006-02-23 Issue:8 Volume:354 Page:809-820
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Joensuu Heikki,Kellokumpu-Lehtinen Pirkko-Liisa,Bono Petri,Alanko Tuomo,Kataja Vesa,Asola Raija,Utriainen Tapio,Kokko Riitta,Hemminki Akseli,Tarkkanen Maija,Turpeenniemi-Hujanen Taina,Jyrkkiö Sirkku,Flander Martti,Helle Leena,Ingalsuo Seija,Johansson Kaisu,Jääskeläinen Anna-Stina,Pajunen Marjo,Rauhala Mervi,Kaleva-Kerola Jaana,Salminen Tapio,Leinonen Mika,Elomaa Inkeri,Isola Jorma

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa053028

Cited by 1220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nonparametric framework for treatment effect modifier discovery in high dimensions;Journal of the Royal Statistical Society Series B: Statistical Methodology;2024-08-21

2. Folate-conjugated carbon nanotubes as a promising therapeutic approach for targeted cancer therapy;Journal of Drug Targeting;2024-08-20

3. Annotation-efficient deep learning for breast cancer whole-slide image classification using tumour infiltrating lymphocytes and slide-level labels;Communications Engineering;2024-07-25

4. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07

5. Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance;Drugs - Real World Outcomes;2024-06-16